- Home
- BMBL vs IMTX Comparison
BMBL vs IMTX Comparison
Compare BMBL & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMBL
- IMTX
- Stock Information
- Founded
- BMBL 2014
- IMTX N/A
- Country
- BMBL United States
- IMTX Germany
- Employees
- BMBL N/A
- IMTX N/A
- Industry
- BMBL Computer Software: Prepackaged Software
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BMBL Technology
- IMTX Health Care
- Exchange
- BMBL Nasdaq
- IMTX Nasdaq
- Market Cap
- BMBL 446.5M
- IMTX 514.2M
- IPO Year
- BMBL 2021
- IMTX N/A
- Fundamental
- Price
- BMBL $4.36
- IMTX $4.26
- Analyst Decision
- BMBL Hold
- IMTX Strong Buy
- Analyst Count
- BMBL 16
- IMTX 4
- Target Price
- BMBL $7.38
- IMTX $16.67
- AVG Volume (30 Days)
- BMBL 3.3M
- IMTX 849.5K
- Earning Date
- BMBL 05-07-2025
- IMTX 05-13-2025
- Dividend Yield
- BMBL N/A
- IMTX N/A
- EPS Growth
- BMBL N/A
- IMTX N/A
- EPS
- BMBL N/A
- IMTX 0.14
- Revenue
- BMBL $1,071,643,000.00
- IMTX $161,336,577.00
- Revenue This Year
- BMBL N/A
- IMTX N/A
- Revenue Next Year
- BMBL N/A
- IMTX $18.80
- P/E Ratio
- BMBL N/A
- IMTX $29.39
- Revenue Growth
- BMBL 1.88
- IMTX 188.60
- 52 Week Low
- BMBL $3.55
- IMTX $3.30
- 52 Week High
- BMBL $12.49
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- BMBL 47.61
- IMTX 48.54
- Support Level
- BMBL $3.90
- IMTX $4.03
- Resistance Level
- BMBL $4.17
- IMTX $4.48
- Average True Range (ATR)
- BMBL 0.29
- IMTX 0.39
- MACD
- BMBL 0.08
- IMTX 0.05
- Stochastic Oscillator
- BMBL 81.82
- IMTX 75.00
About BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.